Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
73.30
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Elliott Wave Technical Analysis: Gilead Inc.
February 16, 2023
Looking for a clear three wave move in wave (ii) to then place longs.
Via
Talk Markets
Lattice Semiconductor To Rally 33%? Here Are 10 Other Analyst Forecasts For Tuesday
February 14, 2023
Goldman Sachs boosted the price target for Kaiser Aluminum Corporation (NASDAQ: KALU) from $70 to $80. Goldman Sachs analyst Emily Chieng maintained a Sell rating on the stock. Kaiser Aluminum shares...
Via
Benzinga
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
February 13, 2023
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends.
Via
Talk Markets
ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood
February 13, 2023
Why does Wall Street hate Cathie Wood and her ARKK ETF? Seven words show how her focus on innovation divides investors.
Via
InvestorPlace
Gilead Issues Unexpectedly Bullish Outlook After Cancer Drug Sales Rocket
February 02, 2023
The company posted another massive quarter for cancer treatment sales.
Via
Investor's Business Daily
Earnings Outlook For Gilead Sciences
February 01, 2023
Via
Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $400 Today
January 27, 2023
Via
Benzinga
Could Gilead Sciences Stock Help You Become a Millionaire?
January 26, 2023
Does Gilead have enough growth potential to become a market-beating investment?
Via
The Motley Fool
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia Settings
February 09, 2023
Kite, a Gilead Sciences Inc (NASDAQ: GILD) company, announced the three-year follow-up results from the pivotal ZUMA-3 study of the CAR T-cell therapy Tecartus (brexucabtagene autoleucel).
Via
Benzinga
2 Biotech Stocks That Could Make You Richer
February 09, 2023
Patience will pay off with these two stocks.
Via
The Motley Fool
Thoughts For Thursday: Risk-off, Risk-on
February 09, 2023
The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible.
Via
Talk Markets
NeurAxis: Should You Buy This IPO?
February 08, 2023
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.
Via
Talk Markets
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
February 06, 2023
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
Via
Talk Markets
16 Analysts Have This to Say About Gilead Sciences
January 19, 2023
Via
Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.
Via
The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
February 03, 2023
The major indexes continued to run despite mixed-to-weak earnings.
Via
Investor's Business Daily
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
February 03, 2023
Via
Benzinga
'Risk Of Overheating': 4 Experts On Hot January Jobs Report, How The Fed Will React
February 03, 2023
The SPDR S&P 500 ETF Trust (NYSE: SPY) traded lower Friday after the Labor Department reported blowout U.S. jobs market numbers from January.
Via
Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
Trading in the U.S. index futures suggests stocks may end a solidly positive week on a negative note. That said, the data-dependency of the Fed places the onus of providing trading cues to each...
Via
Benzinga
Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?
February 03, 2023
Gilead's strongest growth since 2015 comes with an asterisk.
Via
The Motley Fool
Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript
February 02, 2023
GILD earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why Gilead Sciences Stock Is Trading Higher After Hours
February 02, 2023
Gilead Sciences Inc (NASDAQ: GILD) shares are trading higher in Thursday's after-hours session after the company reported
Via
Benzinga
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
February 02, 2023
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging.
Via
Benzinga
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
3 Smart Stocks to Buy if a Recession Is on the Way
January 21, 2023
Their products will enjoy strong demand regardless of what happens with the economy.
Via
The Motley Fool
3 Stocks That Beat the S&P During the Great Recession
January 18, 2023
These stocks could be safe places to store your money if a recession takes place this year.
Via
The Motley Fool
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.
Via
Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
Peering Into Gilead Sciences's Recent Short Interest
January 11, 2023
Gilead Sciences's (NASDAQ:GILD) short percent of float has fallen 15.71% since its last report. The company recently reported that it has 14.76 million shares sold short, which is 1.18% of all regular...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.